The Translational Research Grant (TRG) program funds projects that explore commercial applications or initiate the early commercial development of university-held life sciences inventions.
Donor Name: North Carolina Biotechnology Center
State: North Carolina
County: All Counties
Type of Grant: Grant
Deadline: 02/01/2023
Size of the Grant: $10,000
Grant Duration: 2 years
Details:
North Carolina’s technology-based economy is fueled by the innovative research taking place in universities and research institutions across the state, but groundbreaking ideas are just the beginning. The results of basic research must successfully undergo the translational phase of development in order to result in the new technologies and products that solve problems and foster economic growth. NCBiotech is committed to supporting North Carolina’s life sciences researchers through this critical stage and to maximizing the impact of university research in the marketplace.
The technology must have the potential to solve a real-world problem as a commercial product in the life sciences sector.
Goals of the TRG program
- Transform basic research discoveries into product-focused translational research development
- Generate data that addresses important product development milestones, addresses the concerns of potential licensees or investors, or otherwise de-risks the technology for a specific commercial application
- Enable strategic “go/no-go” decision-making regarding further technology development or pursuit of intellectual property protection
- Enable technology licensing efforts by the university
- Establish goal-oriented partnerships between university scientists, product development professionals, and key stakeholders
Funding Information
A maximum of $100,000 may be requested, with a $10,000 supplement available to engage the required project manager.
Project Duration
Projects may last up to 24 months.
Eligibility Criteria
Eligible Institutions
- Proposals may be submitted by any North Carolina university or non-profit research organization.
- Projects that appear to be subsidized R&D for any commercial entity may be administratively declined. Direct funding of R&D expenses for commercial firms, except contracted services, even if they have ties to NC-based universities and research institutions, is not consistent with the objectives of the program.
Principal Investigator Eligibility
- At the time of submission, the Principal Investigator (PI) must hold a full-time, tenure-track or tenured faculty appointment, or an appointment as full-time research faculty with a dedicated independent lab at the applicant institution, or an equivalent faculty designation in a medical/professional school.
- The PI may not have more than two active awards from the North Carolina Biotechnology Center at the same time.
Intellectual Property Eligibility
- Eligible projects support inventions that, at a minimum, have been disclosed to the university’s technology transfer office at the time of application.
- The applicant must attest that the IP rights are assigned to the applicant’s institution and have not been committed through license or option to license to any third party at the time of application.
For more information, visit Translational Research Grant.
